Nimesulide is a non steroidal anti inflammatory (NSAID) which possesses analgesic and antipyretic properties. Nimesulide has superior gastrointestinal safety as compared to other NSAIDs .Its approved indications are the treatment of acute pain, the symptomatic treatment of osteoarthiritis and primary dysmennorhea.
Paracetamol is commonly used for its analgesic and antipyretic effects. It is used for the temporary relief from fever, minor aches and pain.
Indications and Usage
- Lower back pain
Rationale of Combination
Product Description:The therapeutic effects of Nimesulide are the result of its complete mode of action which targets a number of key mediators of the inflammatory process such as: COX-2 mediated prostaglandins, free radicals, proteolytic enzymes and histamine. Whereas, Paracetamol is major ingredient in numerous cold and flu medications and many prescription analgesics. At therapeutic doses Paracetamol does not irritate the lining of the stomach nor affect blood coagulation, kidney function, or the fetal ductus arteriosus but lacks anti inflammatory action which is substituted with the addition of Nimesulide in combination. The fixed dose combination of Nimesulide and Paracetamol demonstrate a quicker onset and longer duration of antipyretic and analgesic action.
Nimesulide:Nimesulide is rapidly absorbed following oral administration. Food, gender and advanced age have negligible effects on Nimesulide pharmacokinetics. The protein binding of Nimesulide is >97.5%. Nimesulide posses a shorter half life (1.8-4.7) and is hepatically metabolized. 50% of the drug is renally eliminated.
Paracetamol:Paracetamol is a widely used analgesic and antipyretic agent. Paracetamol is well absorbed in gastro intestinal tract. Oral bioavailability is dose dependant since the half life of Paracetamol is 1-3hrs. Paracetamol is distributed throughout the body fluids in a homogeneous way. Paracetamol given at therapeutic doses binds to plasma proteins at less than 20%Metabolites are excreted through the kidneys in the urine
Potentially Fatal:Nimesulide is banned for its usage in children below 12 years since it induces liver toxicity.